Delivery Order SPE2D021DA002-SPE2D326F9216
Award Date 4/1/26
Potential Completion Date 4/2/26
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for procainamide 1 gram/10 mL vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 3, 2026, for procainamide 1 gram/10 mL vials. The order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler based...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for Procainamide 1 gram/10 mL vial (10 mL), with an ultimate completion date of April 2, 2026. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion single-award IDC with a ceiling value of $499,999,999 and completion through December 31, 2036. The program...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 8, 2026, for procainamide 1 gram/10 mL vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract with a $499.9 billion ceiling that authorizes firm fixed-price calls for pharmaceutical products and medical consumables supporting...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for procainamide 1 gram/10 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is the Defense Logistics Agency's $30.3 billion pharmaceutical prime vendor acquisition strategy authorizing issuance of firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, for $3,132.00 (ceiling value) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency-administered indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations globally. The order procures Procainamide 1 gram per 10 milliliter vials. Place of performance is Park Ridge,...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,210.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Procainamide 1 gram/10 mL vials. The contract, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency issued a $1,530.77 delivery order to DMS Pharmaceutical Group Inc. on April 7, 2026, for procainamide 1 gram per 10 milliliter vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support military...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 6, 2026, for procainamide 1 gram/10 ml vial with a ceiling value of $6,123.08, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain issued a $248,324.18 delivery order to DMS Pharmaceutical Group Inc. on March 19, 2026, for pharmaceutical and medical supply products, with an ultimate completion date of April 26, 2027. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery...